TG/HDL-C比值与冠心病患者致病风险的关系及诊断价值

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (636 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the relationship between triglyceride / high density lipoprotein cholesterol (TG / HDL-C) ratio and the risk of coronary heart disease (CHD) and its diagnostic value. Methods One hundred patients with CHD (CHD group) and 100 patients without CHD (non-CHD group) admitted to the People’s Hospital of Liaoning Province from June 2017 to June 2019 were selected as the research objects. The differences of TG / HDL-C ratio and general data between the two groups were compared. The risk of CHD induced by TG / HDL-C ratio was analyzed by multivariate logistic regression. Receiver operating characteristic (ROC) curve was used to evaluate its diagnostic value. Results The levels of TG / HDL-C ratio and TG and the percentages of history of hypertension and family history of CHD in CHD group were significantly higher than those in non-CHD group, while the level of HDL-C was significantly lower than that in non-CHD group, the differences were statistically significant (all P ＜ 0.05). Multivariate logistic regression analysis showed that TG (OR = 1.021, P ＜ 0.001), TG/HDL-C ratio (OR = 4.231, P = 0.006), history of hypertension (OR = 5.724, P ＜ 0.001) and family history of CHD (OR = 3.614, P ＜ 0.001) were all independent risk factors for CHD, while HDL-C (OR = 0.196, P = 0.010) were protective factors. ROC curve analysis showed that among TG, HDL-C and TG/HDL-C ratios, the area under curve (AUC) of TG/HDL-C ratio was the largest (AUC=0.859, P ＜ 0.05). Conclusion The TG / HDL-C ratio of CHD patients is significantly higher than that of non-CHD patients, which has higher diagnostic value for CHD and is an independent risk factor for the occurrence of CHD.

Key words： Coronary heart disease Triacylglycerol / high density lipoprotein cholesterol ratio Risk factors Diagnostic value

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YANG Lin1 GE Baiping2 JIANG Shan3 FU Qiang1 LIU Wenshu1 ZHAO Linlin4

Cite this article:

YANG Lin1 GE Baiping2 JIANG Shan3 FU Qiang1 LIU Wenshu1 ZHAO Linlin4. Relationship between TG / HDL-C ratio and the risk of coronary heart disease and its diagnostic value[J]. 中国医药导报, 2021, 18(11): 66-69.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I11/66

[1] 颜红兵，霍勇.《2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南》——冠状动脉疾病治疗：从归类走向精准[J].中国介入心脏病学杂志，2019，27（9）：481-483.
[2] Liu W，Wang T，Sun P，et al. Expression of Hcy and blood lipid levels in serum of CHD patients and analysis of risk factors for CHD [J]. Exp Ther Med，2019，17（3）：1756-1760.
[3] Lee JS，Chang PY，Zhang Y，et al. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status：The Strong Heart Study [J]. Diabetes Care，2017，40（4）：529-537.
[4] 高秀鑫，丁振江，王文丰，等.三酰甘油/高密度脂蛋白胆固醇比值与冠心病的患病风险[J].临床心血管病杂志，2019，35（12）：1085-1088.
[5] Pahlavanzade B，Zayeri F，Baghfalaki T，et al. Association of lipid markers with coronary heart disease and stroke mortality：A 15-year follow-up study [J]. Iran J Basic Med Sci，2019，22（11）：1325-1330.
[6] 黄震华.高三酰甘油血症和动脉粥样硬化[J].中国新药与临床杂志，2015，34（11）：813-817.
[7] Cheraghi M，Shahsavari G，Maleki A，et al. Paraoxonase 1 Activity，Lipid Profile，and Atherogenic Indexes Status in Coronary Heart Disease [J]. Rep Biochem Mol Biol，2017， 6（1）：1-7.
[8] Okosun IS，Okosun B，Lyn R，et al. Surrogate indexes of insulin resistance and risk of metabolic syndrome in non-Hispanic White，non-Hispanic Black and Mexican American [J]. Diabetes Metab Syndr，2020，14（1）：3-9.
[9] 中国医师协会急诊医师分会，中华医学会心血管病学分会，中华医学会检验医学分会.急性冠脉综合征急诊快速诊疗指南[J].中华急诊医学杂志，2016，25（4）：397-404.
[10] 高润霖.进一步改善稳定性冠心病的诊治：浅谈“中国稳定性冠心病诊断与治疗指南”亮点[J].中华心血管病杂志，2018，46（11）：833-836.
[11] 冯高科，汪小丁，陈晶晶，等.冠心病危险因素与冠脉病变程度的相关分析[J].中国医师杂志，2018，20（1）：72-75.
[12] Popa S，Mota M，Popa A，et al. Prevalence of dyslipidemia and its association with cardiometabolic factors and kidney function in the adult Romanian population：The PREDATORR study [J]. Diabetes Metab Syndr，2019， 13（1）：596-602.
[13] 张琳枫，董耀荣.冠心病危险因素研究进展[J].中西医结合心血管病电子杂志，2020，8（18）：21，52.
[14] 王慧，徐新豫.冠心病的影响因素分析[J].中国当代医药，2020，27（23）：68-71.
[15] 杜艳梅，单海燕，于晓松，等.冠状动脉粥样硬化性心脏病危险因素的研究进展[J].中国实用乡村医生杂志，2019， 26（10）：29-32.
[16] Yang Q，Wang JH，Huang DD，et al. Clinical significance of analysis of the level of blood fat，CRP and hemorheological indicators in the diagnosis of elder coronary heart disease [J]. Saudi J Biol Sci，2018，25（8）：1812-1816.
[17] Tabrizi JS，Nikniaz L，Sadeghi-Bazargani H，et al. Prevalence of Dyslipidemia in Urban and Rural Areas of the Northwest of Iran：The Sociodemographic，Dietary and Psychological Determinants [J]. Iran J Public Health，2019， 48（5）：925-933.
[18] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南（2016年修订版）[J].中国循环杂志，2016，31（10）：937-950.
[19] 刘瑞双，黄方洋，陈茂.三酰甘油水平对冠状动脉粥样硬化性心脏病影响的研究进展[J].华西医学，2017，32（5）：763-767.
[20] 熊芳，王宗保，唐朝克.富含甘油三酯脂蛋白代谢及其在动脉粥样硬化中的作用[J].中国动脉硬化杂志，2019， 27（1）：81-86.
[21] 李小军，马涛.血清高密度脂蛋白胆固醇对冠心病病人冠状动脉病变的影响[J].中西医结合心脑血管病杂志，2017，15（18）：2347-2349.
[22] 叶平.血清高密度脂蛋白胆固醇对冠心病病人冠状动脉病变程度的诊断价值分析[D].合肥：安徽医科大学，2018：1-38.
[23] 孙立山，范列英.重新认识高密度脂蛋白与动脉粥样硬化的关系[J].中华检验医学杂志，2017，40（6）：470-474.
[24] 李亚，李曙，马于林，等.单核细胞/高密度脂蛋白胆固醇比值与冠心病关系的探讨[J].中国心血管病研究，2019， 17（12）：1110-1114.
[25] 卢群，张笈，田刚，等.各血脂指标与高密度脂蛋白胆固醇比值对冠心病的诊断价值[J].山西医科大学学报，2017， 48（9）：883-886.
[26] 洪桂玲，郑文华.冠心病患者血脂指标比值对病情严重程度的评估价值[J].现代实用医学，2016，28（5）：609-610，678.